Biomerica, Inc. (BMRA) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 987K | 1.21M | 1.38M | 749K | 1.12M | 1.64M | 1.81M | 1.12M | 1.02M | 1.57M | 1.71M | 1.11M |
| Revenue Growth % | -11.8% | -26.04% | -23.63% | -32.89% | 10.03% | 4.4% | 5.49% | 0.7% | -8.5% | 5.74% | 4.61% | -79.1% |
| Cost of Goods Sold | 1.03M | 1.16M | 956K | 993K | 1.1M | 1.2M | 1.52M | 1.1M | 1.17M | 1.24M | 1.3M | 1.08M |
| COGS % of Revenue | 104.46% | 95.79% | 69.28% | 132.58% | 98.3% | 73.29% | 84.01% | 98.21% | 114.65% | 79.26% | 75.95% | 97.4% |
| Gross Profit | -44K | 51K | 424K | -244K | 19K | 437K | 289K | 20K | -149K | 325K | 412K | 28.81K |
| Gross Margin % | -4.46% | 4.21% | 30.72% | -32.58% | 1.7% | 26.71% | 15.99% | 1.79% | -14.65% | 20.74% | 24.05% | 2.6% |
| Gross Profit Growth % | -331.58% | -88.33% | 46.71% | -1320% | 112.75% | 34.46% | -29.85% | -30.57% | -223.88% | -7.64% | 849.7% | -95.36% |
| Operating Expenses | 1.25M | 1.42M | 1.54M | 1.32M | 1.23M | 1.43M | 1.66M | 1.55M | 1.85M | 1.93M | 1.64M | 1.86M |
| OpEx % of Revenue | 127.05% | 117.69% | 111.74% | 176.24% | 109.83% | 87.41% | 91.7% | 138.71% | 182.01% | 123.36% | 95.97% | 168.25% |
| Selling, General & Admin | 1.08M | 1.23M | 1.33M | 1.07M | 1.01M | 1.17M | 1.36M | 1.28M | 1.51M | 1.52M | 1.17M | 1.5M |
| SG&A % of Revenue | 109.02% | 101.74% | 96.38% | 142.59% | 90.44% | 71.7% | 75.26% | 114.96% | 148.28% | 97.06% | 68.42% | 134.97% |
| Research & Development | 178K | 193K | 212K | 252K | 217K | 257K | 297K | 265K | 343K | 412K | 472K | 368.86K |
| R&D % of Revenue | 18.03% | 15.95% | 15.36% | 33.64% | 19.39% | 15.71% | 16.44% | 23.75% | 33.73% | 26.29% | 27.55% | 33.28% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.3M | -1.37M | -1.12M | -1.56M | -1.21M | -993K | -1.37M | -1.53M | -2M | -1.61M | -1.23M | -1.84M |
| Operating Margin % | -131.51% | -113.47% | -81.01% | -208.81% | -108.13% | -60.7% | -75.71% | -136.92% | -196.66% | -102.62% | -71.92% | -165.65% |
| Operating Income Growth % | -7.27% | -38.27% | 18.27% | -2.36% | 39.5% | 38.25% | -11.04% | 16.77% | -21.13% | 3.49% | 40.48% | -4.52% |
| EBITDA | -1.19M | -1.27M | -1.02M | -1.46M | -1.11M | -893K | -1.27M | -1.43M | -1.91M | -1.52M | -1.14M | -1.75M |
| EBITDA Margin % | -120.87% | -104.96% | -73.62% | -194.93% | -99.29% | -54.58% | -70.34% | -128.23% | -187.41% | -96.81% | -66.55% | -158.16% |
| EBITDA Growth % | -7.38% | -42.22% | 20.06% | -2.03% | 41.71% | 41.13% | -11.49% | 18.36% | -21.76% | 3.98% | 42.25% | -20.59% |
| D&A (Non-Cash Add-back) | 105K | 103K | 102K | 104K | 99K | 100K | 97K | 97K | 94K | 91K | 92K | 83.08K |
| EBIT | -1.3M | -1.31M | 5K | -1.54M | -1.17M | -953K | -1.31M | -1.41M | -1.91M | -1.5M | -1.11M | -1.78M |
| Net Interest Income | -6K | 58K | 1.12M | 25K | 43K | 40K | 56K | 114K | 86K | 109K | 123K | 55.63K |
| Interest Income | -6K | 58K | 1.12M | 25K | 43K | 40K | 56K | 114K | 86K | 109K | 123K | 55.63K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -6K | 58K | 1.12M | 25K | 43K | 40K | 56K | 114K | 86K | 109K | 123K | 56.63K |
| Pretax Income | -1.3M | -1.31M | 5K | -1.54M | -1.17M | -953K | -1.31M | -1.41M | -1.91M | -1.5M | -1.11M | -1.78M |
| Pretax Margin % | -132.12% | -108.68% | 0.36% | -205.47% | -104.29% | -58.25% | -72.61% | -126.7% | -188.2% | -95.66% | -64.74% | -160.54% |
| Income Tax | 8K | 5K | 3K | 5K | -4K | -3K | 4K | 7K | 4K | 8K | 23K | 13.01K |
| Effective Tax Rate % | -0.61% | -0.38% | 60% | -0.32% | 0.34% | 0.31% | -0.3% | -0.5% | -0.21% | -0.53% | -2.07% | -0.73% |
| Net Income | -1.31M | -1.32M | 2K | -1.54M | -1.16M | -950K | -1.32M | -1.42M | -1.92M | -1.51M | -1.13M | -1.79M |
| Net Margin % | -132.93% | -109.09% | 0.14% | -206.14% | -103.93% | -58.07% | -72.83% | -127.33% | -188.59% | -96.17% | -66.08% | -161.72% |
| Net Income Growth % | -12.81% | -38.95% | 100.15% | -8.66% | 39.36% | 36.96% | -16.25% | 20.71% | -16.25% | 7.32% | 45.36% | -1.88% |
| Net Income (Continuing) | -1.31M | -1.32M | 2K | -1.54M | -1.16M | -950K | -1.32M | -1.42M | -1.92M | -1.51M | -1.13M | -1.79M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.44 | -0.45 | 0.00 | -0.16 | -0.07 | -0.06 | -0.08 | -0.08 | -0.11 | -0.09 | -0.07 | -0.11 |
| EPS Growth % | -548.01% | -710.81% | 103.84% | -89.35% | 38.27% | 38.06% | -16.2% | 23.18% | 8.33% | 25.33% | 57.94% | 21.43% |
| EPS (Basic) | -0.44 | -0.45 | 0.00 | -0.16 | -0.07 | -0.06 | -0.08 | -0.08 | -0.11 | -0.09 | -0.07 | -0.11 |
| Diluted Shares Outstanding | 3.01M | 2.91M | 2.64M | 9.71M | 17.12M | 17.12M | 16.82M | 16.82M | 16.82M | 16.82M | 16.82M | 16.82M |
| Basic Shares Outstanding | 3.01M | 2.91M | 2.64M | 9.71M | 17.12M | 17.12M | 16.82M | 16.82M | 16.82M | 16.82M | 16.82M | 16.82M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |